XP Inc. (NASDAQ: XP) traded down about 4.8% to $17.71, extending weakness as traders focused on regulatory uncertainty around prediction markets in Brazil. The selling pressure follows heightened attention on whether event-based “prediction market” contracts can be legally offered and marketed locally, creating a near-term overhang for sentiment even as the company continues to emphasize governance and education in new product rollouts. (marvn.ai)

XP recently disclosed a partnership with Kalshi to distribute event-based contracts to Brazilian investors, positioned as an expansion of product access. Days earlier, Brazil’s Secretariat of Prizes and Bets (SPA) issued a public warning stating that no company had been authorized to operate prediction markets in the country—injecting uncertainty into what “permitted” distribution looks like and whether additional approvals, guardrails, or product changes will be required. (news.kalshi.com)

For brokers, headline regulatory ambiguity can quickly translate into concerns about customer communication, compliance costs, potential constraints on marketing, and reputational spillover—especially when the new product category is closely adjacent to wagering and derivatives regulation. With XP’s growth narrative tied to expanding its product shelf and engagement, any perception of a forced pause or delayed launch can pressure the stock even without an earnings update. (marvn.ai)

Investors will look for clarity on whether XP can continue offering the product under an existing framework, needs additional authorizations, or will restrict features until regulators finalize rules. Near-term signposts include formal guidance from Brazilian authorities, any updates from XP on rollout timing and client eligibility, and disclosures in filings or communications that quantify potential revenue impact or compliance changes. (news.kalshi.com)